Hot Life Science Investor Mandate 3: PE Fund Seeking Later Stage Therapeutics, Devices and Diagnostics

25 Sep

A Private Equity group based in the Eastern United States is looking for new firms for potential investments for the firm’s third fund and could make as many as 10 investment over the next year. The firm looks to make equity investments into companies looking to raise a total round of $20-$50 million generally set up in tranches. The firm looks to invest in companies across the United States and Europe with a focus on companies located in the United States.

The firm is interested in Therapeutics, Medical Devices and Diagnostics, though the majority of the firm’s investments have been into the therapeutics space. The firm is primarily interested in later stage opportunities, with a focus on therapeutics that are in Phase II or later and devices and diagnostics that are well into their clinical trial or are already on the market. The firm is opportunistic across technologies types and indications although historically they have worked with a number of companies in the oncology and infectious disease spaces.

The firm is looking for companies with significant competitive advantage and strong, experienced management teams. The firm is willing to invest in both public and privately held companies with a preference for those that are private. The firm is open to both lead and co-investing.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: